Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-22

Clinical Trial Update: Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study [Phase 3]

View source ↗

Summary

A Phase 3 effectiveness study evaluating reconsolidation blockade for trauma-related disorders after Paris attacks in PTSD patients, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Post-traumatic Stress Disorder | Phase 3 | Status: COMPLETED